Hahnemann and used by homeopathic practitioners and researchers around the world.įront Matter - Introduction. Riley, in an attempt to improve transparency and reduce bias, has incorporated elements of contemporary research methods such as randomization, blinding, and formal good clinical practice guidelines (GCP) into homeopathic drug provings, while adhering to the general guidelines suggested by Dr. Scientific research methods have evolved from the early days of homeopathy and Dr. Hahnemann's time the method by which the treatment profiles of homeopathic remedies were determined were called provings, after the original German word Prüfung, which means "test". The 69 drug homeopathic drug provings published here, are the result of his investigation of the research methods of homeopathic drug provings that forms part of the basis for prescribing in homeopathy. Pharmacokinetics of Anticancer Materia Medica in Humans / Shu-Feng Zhou.ĭavid Riley's interest in the history, methodology, and results of homeopathic drug provings came from his study of homeopathy at the Hahnemann College of Homeopathy in Albany, California.
Evidence-based Materia Medica for Cancer Chemoprevention / Sunil Prabhu, Ying Huang, and Jeffrey Wang - 16. Evidence-based Anticancer Materia Medica for Brain Tumors / Prabha Balaram and Faizah Harun - 15. Evidence-based Anticancer Materia Medica for Nasopharyngeal Carcinoma / Guangcun Deng, Jihui Yang, and Yujiong Wang - 14. Evidence-based Anticancer Materia Medica for Leukemia / Min Li-Weber - 13. Evidence-based Anticancer Materia Medica for Pancreatic Cancer / Shwu-Huey Liu and M. Evidence-based Anticancer Materia Medica for Bladder Cancer / Dawei Ye, Pingping Gu, Hongyu Zhao, Michelle Chow, Xiaoqing Guo, and Jianyu Rao - 11. Evidence-based Anticancer Materia Medica for Lymphoma / Eran Ben-Arye, Tamar Tadmor, Aaron Polliack, and Elad Schiff - 10. Evidence-based Anticancer Materia Medica for Esophageal Cancer / Taixiang Wu, Minawaer Abudou, and Shou Chen - 9. Evidence-based Anticancer Materia Medica for Cervical Cancer / Tatjana Stanojković, Aleksandra Konić-Ristić, Teodora Janković, Gordana Zdunić, and Katarina Šavikin - 8. Evidence-based Anticancer Materia Medica for Prostate Cancer / Yi-Ren Chen, Pei-Wen Hsiao, Feng-Ming Lin, Guan-James Wu, and Chin-Hsien Tsai - 7. Evidence-based Anticancer Materia Medica for Hepatocellular Carcinoma / Lei Wan - 6. Evidence-based Anticancer Kampo Medicine for Gastric Cancer / Koji Tanaka, Takeshi Omori, and Toshiro Nishida - 5. An Overview of the Current Development of Phytoremedies for Breast Cancer / Chun-Hung Lin, Wai-Leng Lee, and Lie-Fen Shyur - 4. Evidence-based Anticancer Materia Medica for Colorectal Cancer / Minsig Choi, Ramzi Mohammad, M. Evidence-based Anticancer Materia Medica for Lung Cancer / Constance L.L.
0 kommentar(er)
